Typically, in a c-GMP environment:
If a API was quantified to be 100.6% pure, you must assign the deduced value as such - Determination of API potency.
When the same API will be used to quantify samples, its potency can be rounded to a 100.0% to facilitate quantitation of samples.
Please, add comments.
Can you quote a compendial reference saying it's OK to ignore an assay result , and arbitrarily assigning 100% to the API after having a valid Assay value?.
That's bizarre, can you round up as well as down?. I'd also wonder how regulators would respond to assignation of purity to nominal values.
If the CoA assay was 100.0%, and you got 100.6%, then surely an investigation is called for, depending on the error bars of the CoA assay. If the CoA says 100.0 +-0.5, you've got a problem, and if it says 100+-1, you're OK, but it would not be a good reference compound..
Please keep having fun,
Bruce Hamilton